← All Sponsors
SPONSOR

Panbela Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV
NCT05254171 Phase 2, Phase 3
Recruiting

Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer

Pancreatic Cancer Metastatic
United States, Australia, Austria View Trial →